Egetis Therapeutics AB (publ)

OM:EGTX Stock Report

Market Cap: SEK 1.4b

Egetis Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

OM:EGTX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
07 Jul 23BuySEK 133,704Henrik KrookIndividual33,594SEK 3.98
06 Jul 23BuySEK 27,812Christian SonessonIndividual7,000SEK 3.98
04 Jul 23BuySEK 60,633Nicklas WesterholmIndividual15,350SEK 3.95

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of EGTX?
Owner TypeNumber of SharesOwnership Percentage
VC/PE Firms38,675,50113.2%
Individual Insiders51,488,47317.6%
Private Companies61,976,21121.2%
General Public68,563,41523.4%
Institutions71,867,85924.6%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 17.2%.


Top Shareholders

Top 25 shareholders own 76.51% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
13.2%
Frazier Life Sciences Management, LP
38,675,501SEK 180.6m0%0.98%
11.5%
Cetoros AB
33,776,221SEK 157.7m0%no data
10.3%
Peter Lindell
30,007,682SEK 140.1m0%no data
7.32%
Fourth Swedish National Pension Fund (AP4)
21,404,690SEK 100.0m0%0.05%
6.04%
Avla Holding AB
17,668,330SEK 82.5m0%no data
4.73%
Flerie AB (publ)
13,844,458SEK 64.7m0%9.11%
4.61%
Thomas Eldered
13,499,458SEK 63.0m0%no data
4.04%
Handelsbanken Asset Management
11,831,897SEK 55.3m0%0.01%
3.6%
Recipharm AB (publ)
10,531,660SEK 49.2m0%no data
2.57%
Linc AB
7,532,021SEK 35.2m0%1.89%
2.37%
Unionen, Endowment Arm
6,946,793SEK 32.4m0%0.97%
1.82%
Avanza Fonder AB
5,335,379SEK 24.9m0%0.07%
1.2%
Carl Rosvall
3,520,287SEK 16.4m0%no data
1.07%
Mats Blom
3,134,762SEK 14.6m0%no data
0.5%
SEB Investment Management AB
1,459,551SEK 6.8m1.01%no data
0.39%
Healthinvest Partners AB
1,129,177SEK 5.3m0%0.24%
0.3%
AXA Investment Managers S.A.
873,955SEK 4.1m0%no data
0.21%
FCG Fonder AB
608,885SEK 2.8m0%0.1%
0.17%
Financiere Arbevel
500,000SEK 2.3m0%0.05%
0.12%
Henrik Krook
339,593SEK 1.6m0%no data
0.1%
Yilmaz Mahshid
303,089SEK 1.4m0%no data
0.097%
Thomas Lonngren
283,158SEK 1.3m-0.03%no data
0.095%
Medical Strategy GmbH, Asset Management Arm
277,000SEK 1.3m0%0.01%
0.079%
Nicklas Westerholm
232,576SEK 1.1m9.2%no data
0.042%
Skandia Fonder AB
121,862SEK 569.1k0%no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.